1. Home
  2. HIPO vs KROS Comparison

HIPO vs KROS Comparison

Compare HIPO & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

HOLD

Current Price

$27.26

Market Cap

676.8M

Sector

Finance

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.54

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIPO
KROS
Founded
2015
2015
Country
United States
United States
Employees
540
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
676.8M
584.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HIPO
KROS
Price
$27.26
$11.54
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$38.67
$22.25
AVG Volume (30 Days)
84.6K
411.6K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
N/A
2.30
Revenue
N/A
$243,864,000.00
Revenue This Year
$27.32
N/A
Revenue Next Year
$23.24
$727.07
P/E Ratio
$7.64
$4.84
Revenue Growth
N/A
N/A
52 Week Low
$19.92
$10.42
52 Week High
$38.98
$22.55

Technical Indicators

Market Signals
Indicator
HIPO
KROS
Relative Strength Index (RSI) 56.89 42.72
Support Level $27.00 $10.45
Resistance Level $31.92 $16.12
Average True Range (ATR) 0.82 0.57
MACD 0.24 0.18
Stochastic Oscillator 97.65 44.84

Price Performance

Historical Comparison
HIPO
KROS

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: